Dostarlimab Receives FDA Approval for MSI-H/dMMR Locally Advanced Rectal Cancer
Dostarlimab Receives FDA Approval for MSI-H/dMMR Locally Advanced Rectal Cancer Targeted Oncology
2026
FDA Approves Ryzumvi Eye Drops for Presbyopia
FDA Approves Ryzumvi Eye Drops for Presbyopia Medscape
Haemonetics says FDA clears vascular closure device
Haemonetics says FDA clears vascular closure device Reuters
FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery
The U.S. Food and Drug Administration today granted accelerated approval for a new use of the immunotherapy Jemperli (dostarlimab-gxly) that…